CUIR at Chulalongkorn University: Browsing DSpace

Browsing by Author Pisit Tangkijvanich

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ก ข ฃ ค ฅ ฆ ง จ ฉ ช ซ ฌ ญ ฎ ฏ ฐ ฑ ฒ ณ ด ต ถ ท ธ น บ ป ผ ฝ พ ฟ ภ ม ย ร ฤ ล ฦ ว ศ ษ ส ห ฬ อ ฮ
or enter first few letters:

Showing results 1 to 14 of 14

Issue Date	Title	Author(s)
2023	Analysis of plasma extracellular vesicle-derived microRNAs from patients with nonalcoholic fatty liver disease and hepatocellular carcinoma	Bootsakorn Boonkaew
2022	Analysis of VOCs from exhaled breath for the diagnosis of hepatocellular carcinoma	Thanikarn Suk-aram
2018	B-cell activating factor as an immunological marker of disease outcome and treatment response in patients with chronic hepatitis B virus infection	Apichaya Khlaiphuengsin
2012	The characterization of immune response in patients with viral hapatitis B infection	Pimpayao Sodsai
2020	Circulating-tumor DNA and cancer-induced gene expression as novel liquid biomarkers of liver cancers	Pattapon Kunadirek
2020	G6PD activity, oxidative stress, and Alu methylation in HBV-related hepatocellular carcinoma	Watcharapong Jugnam-ang
2018	Host and viral factors influencing disease progression and treatment response in chronic HBV infection	Umaporn Limothai
2014	INFLUENCE OF HOST AND VIRAL FACTORS IN HEPATITIS C VIRUS INFECTION: ROLE OF TA REPEAT, IFNL3 AND IFNL4 POLYMORPHISMS IN HCV INFECTION AND OUTCOME OF TREATMENT	Vo Duy Thong
2021	Integrative transcriptomic analysis and validation of non-coding RNA in liver cancers	Varunya Virushkul
2015	INTRAHEPATIC AND SERUM MARKERS OF HEPATITIS B VIRUS AS PREDICTORS OF RESPONSE TO PEGYLATED INTERFERON THERAPY	Natthaya Chuaypen
2011	The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients	Sombat Treeprasertsuk
2019	Roles of LIN28 Proteins in Cholangiocarcinoma	Nattapong Puthdee
2019	Serum non-coding RNA levels as potential diagnostic and prognostic markers of hepatocellular carcinoma	Pornpitra Pratedrat
2011	Serum proteomic profile, pre- and post-treatemnt, in chronic hepatitis b patients treated by peg-interferon alfa-2b.	Sunida Kuakarn

Showing results 1 to 14 of 14